Risa Inagaki

Phase Ii Study of Lenvatinib (Len), a Multi-Targeted Tyrosine Kinase Inhibitor, in Patients (Pts) with All Histologic Subtypes of Advanced Thyroid Cancer (Differentiated, Medullary and Anaplastic)

Shunji Takahashi, Makoto Tahara, Naomi Kiyota et al. · Annals of Oncology · 2014 · 25 citations · Full text

Medicine, Oncology, Pharmacology +16

Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study

Masakazu Hatano, Hiroyuki Kamei, Risa Inagaki et al. · Clinical Psychopharmacology and Neuroscience · 2018 · 17 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Application of a quantitative 1H-NMR (1H-qNMR) method for the determination of geniposidic acid and acteoside in Plantaginis semen

Rie Tanaka, Risa Inagaki, Naoki Sugimoto et al. · Journal of Natural Medicines · 2016 · 15 citations

Life Sciences, Biochemistry, Botany +5

Prescription drug survey of elderly patients with degenerative musculoskeletal disorders

Keigo Sato, Risa Inagaki, Takehiro Michikawa et al. · Geriatrics and gerontology international/Geriatrics & gerontology international · 2021 · 15 citations · Full text

Pharmacy, Orthopaedic Surgery, Orthopedic Surgery +17

Efficacy of surgical treatment on polypharmacy of elderly patients with lumbar spinal canal stenosis: retrospective exploratory research

Sota Nagai, Risa Inagaki, Takehiro Michikawa et al. · BMC Geriatrics · 2023 · 11 citations · Full text

Pharmacy, Geriatric Medicine, Pharmacotherapy +9